Dexcom joins FDA TEMPO digital health devices pilot program
DXCM•Dexcom selected for FDA TEMPO pilot
- Dexcom was selected as the first participant in the FDA’s TEMPO pilot program for digital health devices.
- The pilot will support an AI-driven glucose program tied to Dexcom G7 and Stelo, aimed at chronic disease management and real-world evidence generation.
